3Haffner SM, Lehto S, Ronemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-234.
4Laakso M, Lehto S, Penttila I, et al. Lipids and lipoproreins predicting coronary heart disease mortality and morbidity in patients with non-insulin dependetn diabetes. Circulation 1993;88:1421 - 1430.
5Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus(UKPDS:23) :BMJ 1998;316:823-828.
6Lamarche B, Tehemof A, Maurige P, et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998;279:1955-1961.
7Miller M, Seidler A, Kwiterovich PO, et al. Long term predieators of subsequent cardio vascular events with coronary artery disease and "Desirable" levels of plasma total eholerterol.Circulation 1992;86:1165.
8American Diabetes Association: Pathogenesis. In Medical Management of Type 2 Diabetes. 4th ed. American Diabetes Association 1998, p. 19- 16.
9James RW. Boemil M. Sirolla C. et al. Lipoprotein(a)and vascular disease in diabetic patients. Diabetologia 1995;38:711.
10Axelsen M, Smith U, Eriksson J W, et al. Postprandial hypertriglyeeridemia and insulin resistance in normoglyeemia firstdegree relatives of patients with type 2 diabetes. Ann Intern Med 1999;131:27-31.
